Viewing Study NCT03060850


Ignite Creation Date: 2025-12-24 @ 5:10 PM
Ignite Modification Date: 2025-12-25 @ 2:47 PM
Study NCT ID: NCT03060850
Status: UNKNOWN
Last Update Posted: 2019-02-01
First Post: 2017-02-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL
Sponsor: Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module